ZF
VRTX icon

Zhang Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Zhang Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-792
Closed -$353K – 326
2025
Q2 		$353K Sell
792
-524
-40% -$241K 0.02% 226
2025
Q1 		$638K Sell
1,316
-3,315
-72% -$1.54M 0.03% 190
2024
Q4 		$1.86M Buy
4,631
+596
+15% +$276K 0.11% 100
2024
Q3 		$1.88M Buy
4,035
+127
+3% +$61K 0.12% 95
2024
Q2 		$1.83M Buy
3,908
+133
+4% +$57.7K 0.13% 91
2024
Q1 		$1.58M Buy
3,775
+470
+14% +$199K 0.12% 102
2023
Q4 		$1.34M Buy
3,305
+920
+39% +$340K 0.12% 104
2023
Q3 		$829K Buy
2,385
+927
+64% +$324K 0.08% 124
2023
Q2 		$513K Buy
+1,458
New +$491K 0.05% 156

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Zhang Financial's VRTX Position: Q3 2025 in Review

Zhang Financial sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 792 shares — an estimated $353K sold.

Zhang Financial first reported a position in VRTX in Q2 2023 and held it in 9 quarters. The position peaked at $1.88M in Q3 2024. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Zhang Financial reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Zhang Financial sold 792 Vertex Pharmaceuticals shares in Q3 2025, an estimated $353K.
  • Zhang Financial first reported a position in Vertex Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • Zhang Financial's Vertex Pharmaceuticals position peaked at $1.88M in Q3 2024.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Zhang Financial's 13F filing for Q3 2025, filed 10 Nov 2025.